Insulin Infusion Sets and Continuous Glucose Monitoring Sensors: Where the Artificial Pancreas Meets the Patient

Diabetes Technol Ther. 2017 Apr;19(4):206-208. doi: 10.1089/dia.2017.0048.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Glucose / analysis*
  • Device Approval
  • Diabetes Mellitus, Type 1 / blood
  • Diabetes Mellitus, Type 1 / drug therapy*
  • Diabetes Mellitus, Type 1 / surgery
  • Diffusion of Innovation*
  • Equipment Failure
  • Humans
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / therapeutic use
  • Insulin / administration & dosage
  • Insulin / adverse effects
  • Insulin / therapeutic use
  • Insulin Infusion Systems* / adverse effects
  • Monitoring, Ambulatory* / adverse effects
  • Monitoring, Ambulatory* / trends
  • Pancreas, Artificial* / adverse effects
  • Pancreas, Artificial* / trends
  • United States
  • United States Food and Drug Administration

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin